Search

everythinglearnresearchcommunity

for

Search:↓

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The combination treatment showed a higher response rate but no significant survival benefits.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Scalp cooling effectively reduces hair loss from chemotherapy.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Nanoparticle systems make cancer treatment less toxic.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

More research is needed to confirm initial findings on hair loss patterns from chemotherapy.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.